These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2888793)

  • 21. Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.
    Felix SB; Stangl V; Kieback A; Doerffel W; Staudt A; Wernecke KD; Baumann G; Stangl K
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):666-71. PubMed ID: 11602813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade.
    Reilly CS; Wood M; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1985 Nov; 38(5):579-85. PubMed ID: 2865029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of esmolol given during cardiopulmonary bypass on fractional area of contraction from transesophageal echocardiography.
    Cork RC; Azari DM; McQueen KA; Aufderheide S; Mitchell M; Naraghi M
    Anesth Analg; 1995 Aug; 81(2):219-24. PubMed ID: 7618705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternally administered esmolol produces fetal beta-adrenergic blockade and hypoxemia in sheep.
    Eisenach JC; Castro MI
    Anesthesiology; 1989 Nov; 71(5):718-22. PubMed ID: 2573294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation.
    Howie MB; Hiestand DC; Zvara DA; Kim PY; McSweeney TD; Coffman JA
    Anesth Analg; 1992 Nov; 75(5):805-10. PubMed ID: 1358003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.
    Sugiyama A; Takahara A; Hashimoto K
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):70-7. PubMed ID: 10413070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
    Morelli A; Ertmer C; Westphal M; Rehberg S; Kampmeier T; Ligges S; Orecchioni A; D'Egidio A; D'Ippoliti F; Raffone C; Venditti M; Guarracino F; Girardis M; Tritapepe L; Pietropaoli P; Mebazaa A; Singer M
    JAMA; 2013 Oct; 310(16):1683-91. PubMed ID: 24108526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The electrophysiologic properties of esmolol, a short acting beta-blocker.
    Greenspan AM; Spielman SR; Horowitz LN; Laddu A; Senior S
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):209-16. PubMed ID: 2900217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics.
    Wiest D
    Clin Pharmacokinet; 1995 Mar; 28(3):190-202. PubMed ID: 7758250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of esmolol in hypertension after cardiac surgery.
    Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM
    Am J Cardiol; 1985 Oct; 56(11):49F-56F. PubMed ID: 2864849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.
    Kirshenbaum JM; Kloner RA; Antman EM; Braunwald E
    Circulation; 1985 Oct; 72(4):873-80. PubMed ID: 2863013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esmolol: effects on isoprenaline- and exercise-induced cardiovascular stimulation in conscious dogs.
    Fischer G; Grohs JG; Raberger G
    Can J Physiol Pharmacol; 1990 Oct; 68(10):1322-8. PubMed ID: 1981854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
    Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R
    Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of near infrared spectroscopy for detecting the β blocker-induced decrease in cerebral oxygenation during hemodilution in a swine model.
    Kurita T; Morita K; Sato S
    J Clin Monit Comput; 2015 Dec; 29(6):779-88. PubMed ID: 25876017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptomatic and hemodynamic recovery following dobutamine stress echo: benefit of low-dose esmolol administration.
    Abdullah EE; Pollick C
    Int J Card Imaging; 1997 Feb; 13(1):53-7. PubMed ID: 9080239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is esmolol cardioprotective? Tolerance of pacing tachycardia, acute afterloading and hemodilution in dogs with coronary stenosis.
    Spahn DR; Frasco PE; White WD; Smith LR; McRae RL; Leone BJ
    J Am Coll Cardiol; 1993 Mar; 21(3):809-21. PubMed ID: 8094722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esmolol for potentiation of nitroprusside-induced hypotension: impact on the cardiovascular, adrenergic, and renin-angiotensin systems in man.
    Edmondson R; Del Valle O; Shah N; Wong G; Dwyer D; Matarazzo D; Thorne A; Coffey C; Bedford R
    Anesth Analg; 1989 Aug; 69(2):202-6. PubMed ID: 2569849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The electrocardiographic and hemodynamic effect of metohexital and propofol with and without esmolol.
    Korpinen R; Klemola UM; Simola M; Toivonen H
    Acta Anaesthesiol Scand; 2006 Feb; 50(2):188-92. PubMed ID: 16430540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic Effects, Safety, and Feasibility of Intravenous Esmolol Infusion During Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction: Results From A Multicenter Registry.
    Santoro F; Ieva R; Ferraretti A; Fanelli M; Musaico F; Tarantino N; Martino LD; Gennaro LD; Caldarola P; Biase MD; Brunetti ND
    Cardiovasc Ther; 2016 Jun; 34(3):161-6. PubMed ID: 26946520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.